RecruitingNCT06446947

Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis

Identification de Marqueurs de Mauvais Pronostic Clinique du Sepsis Par Analyse épigénétique.


Sponsor

Assistance Publique Hopitaux De Marseille

Enrollment

25 participants

Start Date

Mar 20, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Sepsis is a multifactorial syndrome characterized by a dynamic course and a clinical outcome dependent on several factors, and responsible for one in five deaths worldwide. The aim of this trial is to identify new prognostic markers for the progression of sepsis to septic shock, by comparing epigenetic markers between patients who have or have not developed severe forms of sepsis. The main objective of this preliminary study is to identify prognostic markers for the progression of sepsis to septic shock, i.e. to compare targeted markers between subjects with sepsis who progress to septic shock versus subjects with sepsis who do not progress to septic shock.


Eligibility

Sex: MALEMin Age: 45 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying blood sampling for people with sepsis, sepsis syndrome, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERblood sampling

Blood sampling (6ml) on admission and a second on discharge from intensive care.


Locations(1)

Service Anesthésie Réanimation - Hôpital Nord - Assistance Publique Hôpitaux de Marseille

Marseille, Bouches du Rhône, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06446947


Related Trials